- ￥5538 - 53820
- ichorbio
- ICH5405
- 2026年11月02日
- Functional Assays
- CHO Cells
- Human
企业认证
相关产品推荐更多 >
Anti-Mouse/Human phosphorylated PD-1/CD279 (Tyr248) Antibody (407.6G12), 抗小鼠/Human phosphorylated PD-1/CD279 (Tyr248) 抗体 (407.6G12)
￥191
Research Grade Anti-Human CLDN6 (AMG 794), 研究级Anti-Human CLDN6 (AMG 794)
￥2588
InVivoMAb Anti-HRSV/hMPV Fusion glycoprotein Neutralizing Antibody (M2D2), InVivoMAb 抗HRSV/hMPVFusion glycoprotein Neutralizing抗体 (M2D2)
￥2588
Anti-Borreliella burgdorferi ospB Antibody (SAA2656), 抗Borreliellaburgdorferi ospB抗体 (SAA2656)
询价Anti-PA/pagA/PA-83 Antibody (W1), 抗PA/pagA/PA-83抗体 (W1)
￥1338
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
细胞污染识别与处理全攻略：5 种常见类型+关键误区Cytoscape 教程来了！快速实现顶刊同款通路网络图五大应用案例：Mustang Q 膜层析应用全解析1 个小工具，一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 技术资料
- 亚型：
IgG1 - kappa
- 形态：
Liquid
- 保存条件：
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
- 克隆性：
Recombinant
- 标记物：
Unconjugated
- 适应物种：
Human
- 目录编号：
ICH5405
- 库存：
999
- 供应商：
ichorbio
- 宿主：
CHO Cells
- 应用范围：
Functional Assays
- 浓度：
>1mg/ml
- 靶点：
CD44
- 抗体英文名：
Bivatuzumab Biosimilar - Research Grade
- 规格：
10mg/1mg/25mg/50mg/5mg
| 规格： | 10mg | 产品价格： | ￥20701.0 |
|---|---|---|---|
| 规格： | 1mg | 产品价格： | ￥5538.0 |
| 规格： | 25mg | 产品价格： | ￥27612.0 |
| 规格： | 50mg | 产品价格： | ￥53820.0 |
| 规格： | 5mg | 产品价格： | ￥13806.0 |
Bivatuzumab Biosimilar - Research Grade. Clonality: Recombinant. Host: CHO Cells. Reactivity: Human. Applications: Functional Assays. Form: Liquid. Purity: >90% by SDS-PAGE. Storage: This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.. This product is a research-grade biosimilar of bivatuzumab, supplied as an unconjugated, non-therapeutic analog of the originator antibody for research use only. It is not a clinical drug and carries none of the payloads associated with the originator program. Bivatuzumab is a humanized IgG1 antibody built around CD44, and more specifically the v6 variant epitope of the CD44 adhesion receptor. The originator was developed as a tumor-targeting agent and was best known in its mertansine-conjugated
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料
Bivatuzumab Biosimilar - Research Grade
￥5538 - 53820
